Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Administration Aids”

279 trials

Showing 20 of 279 results

Post-approval studies (Phase 4)UnknownNCT00526448
What this trial is testing

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Who this might be right for
Chronic Hepatitis C
Hospital Carlos III, Madrid 384
Post-approval studies (Phase 4)Study completedNCT00466180
What this trial is testing

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University Hospital, Caen 62
Testing effectiveness (Phase 2)Study completedNCT01338883
What this trial is testing

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 143
Testing effectiveness (Phase 2)WithdrawnNCT00397566
What this trial is testing

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00272779
What this trial is testing

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Who this might be right for
HIV Infections
Bristol-Myers Squibb 1,057
Not applicableEnded earlyNCT01474954
What this trial is testing

Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors

Who this might be right for
HIV Infection
University of California, San Francisco 5
Large-scale testing (Phase 3)UnknownNCT04140461
What this trial is testing

AmB Dose for Cryptococcal Meningitis

Who this might be right for
Cryptococcal MeningitisHIV Infections
Shanghai Public Health Clinical Center 40
Early research (Phase 1)Study completedNCT00002087
What this trial is testing

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

Who this might be right for
HIV Infections
Pharmacia and Upjohn
Testing effectiveness (Phase 2)Study completedNCT00622206
What this trial is testing

Pharmacokinetics of Low Dose Ritonavir

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Large-scale testing (Phase 3)Study completedNCT02670772
What this trial is testing

Dose Optimisation of Stavudine for the Treatment of HIV Infection

Who this might be right for
Acquired Immune Deficiency SyndromeHuman Immunodeficiency Virus
Willem Daniel Francois Venter 1,077
Large-scale testing (Phase 3)Study completedNCT02777229
What this trial is testing

Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 616
Large-scale testing (Phase 3)UnknownNCT04145258
What this trial is testing

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

Who this might be right for
Tuberculous Meningitis
ANRS, Emerging Infectious Diseases 768
Testing effectiveness (Phase 2)Study completedNCT03045861
What this trial is testing

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
GlaxoSmithKline 33
Testing effectiveness (Phase 2)Study completedNCT04975698
What this trial is testing

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

Who this might be right for
HIV Associated Lymphoma
Catherine Bollard 12
Testing effectiveness (Phase 2)Study completedNCT02384967
What this trial is testing

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients

Who this might be right for
HIV INFECTION
ANRS, Emerging Infectious Diseases 100
Post-approval studies (Phase 4)Study completedNCT00356486
What this trial is testing

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 74
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Post-approval studies (Phase 4)Study completedNCT00299091
What this trial is testing

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

Who this might be right for
HIV
Germans Trias i Pujol Hospital 31
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation